Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Neil Ferguson and Christl Donnelly.
Connection Strength

3.126
  1. Reduction in mobility and COVID-19 transmission. Nat Commun. 2021 02 17; 12(1):1090.
    View in: PubMed
    Score: 0.232
  2. SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China. J Travel Med. 2020 12 23; 27(8).
    View in: PubMed
    Score: 0.230
  3. Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. Int J Infect Dis. 2021 Jan; 102:463-471.
    View in: PubMed
    Score: 0.228
  4. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 06; 20(6):669-677.
    View in: PubMed
    Score: 0.219
  5. International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017. Euro Surveill. 2017 Jul 13; 22(28).
    View in: PubMed
    Score: 0.181
  6. Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos Trans R Soc Lond B Biol Sci. 2017 May 26; 372(1721).
    View in: PubMed
    Score: 0.179
  7. Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci U S A. 2016 08 09; 113(32):9081-6.
    View in: PubMed
    Score: 0.169
  8. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014 Jan; 14(1):50-56.
    View in: PubMed
    Score: 0.141
  9. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013 Jun 13; 18(24).
    View in: PubMed
    Score: 0.136
  10. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004 Nov; 4(11):672-83.
    View in: PubMed
    Score: 0.075
  11. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003 May 24; 361(9371):1761-6.
    View in: PubMed
    Score: 0.068
  12. Author Correction: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'. Nat Commun. 2021 Aug 12; 12(1):5020.
    View in: PubMed
    Score: 0.060
  13. Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling. Sci Rep. 2021 08 11; 11(1):16342.
    View in: PubMed
    Score: 0.060
  14. SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'. Nat Commun. 2021 07 19; 12(1):4383.
    View in: PubMed
    Score: 0.060
  15. Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries. Int J Epidemiol. 2021 07 09; 50(3):753-767.
    View in: PubMed
    Score: 0.060
  16. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Sci Transl Med. 2021 07 14; 13(602).
    View in: PubMed
    Score: 0.060
  17. The J-IDEA Pandemic Planner: A Framework for Implementing Hospital Provision Interventions During the COVID-19 Pandemic. Med Care. 2021 05 01; 59(5):371-378.
    View in: PubMed
    Score: 0.059
  18. Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions. Nat Commun. 2021 04 12; 12(1):2188.
    View in: PubMed
    Score: 0.059
  19. Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2021 Feb; 590(7844):E11.
    View in: PubMed
    Score: 0.058
  20. State-level tracking of COVID-19 in the United States. Nat Commun. 2020 12 03; 11(1):6189.
    View in: PubMed
    Score: 0.057
  21. Host or pathogen-related factors in COVID-19 severity? - Authors' reply. Lancet. 2020 10 31; 396(10260):1397.
    View in: PubMed
    Score: 0.057
  22. Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020 10 09; 18(1):321.
    View in: PubMed
    Score: 0.057
  23. Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Res. 2020; 5:81.
    View in: PubMed
    Score: 0.057
  24. Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UK. Wellcome Open Res. 2020; 5:170.
    View in: PubMed
    Score: 0.056
  25. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 09; 8(9):e1132-e1141.
    View in: PubMed
    Score: 0.056
  26. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 2020 08; 584(7821):425-429.
    View in: PubMed
    Score: 0.056
  27. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science. 2020 07 24; 369(6502):413-422.
    View in: PubMed
    Score: 0.055
  28. Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020 06 20; 395(10241):e110-e111.
    View in: PubMed
    Score: 0.055
  29. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 08; 584(7820):257-261.
    View in: PubMed
    Score: 0.055
  30. COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply. Lancet Infect Dis. 2021 01; 21(1):28.
    View in: PubMed
    Score: 0.055
  31. Key data for outbreak evaluation: building on the Ebola experience. Philos Trans R Soc Lond B Biol Sci. 2017 May 26; 372(1721).
    View in: PubMed
    Score: 0.045
  32. Ebola Virus Disease among Male and Female Persons in West Africa. N Engl J Med. 2016 01 07; 374(1):96-8.
    View in: PubMed
    Score: 0.041
  33. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006 Apr; 134(2):211-21.
    View in: PubMed
    Score: 0.021
  34. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
    View in: PubMed
    Score: 0.019
  35. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1091-105.
    View in: PubMed
    Score: 0.018
  36. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 Jun 20; 300(5627):1961-6.
    View in: PubMed
    Score: 0.017
  37. Viral replication under combination antiretroviral therapy: a comparison of four different regimens. J Acquir Immune Defic Syndr. 2002 Jun 01; 30(2):167-76.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.